NICE backflips on Sanofi's Gaucher med Cerdelga by Carly Helfand Thursday, June 1, 2017 Three months ago, England’s cost watchdogs nixed Sanofi's Gaucher treatment Cerdelga. But they're already singing a different tune.
Sanofi Genzyme chief Meeker bows out, Sibold steps in by Tracy Staton Wednesday, April 5, 2017 As Sanofi's Genzyme unit gears up for a blockbuster Dupixent launch, CEO David Meeker is making an exit, with insider Bill Sibold taking his place.
